A Novel Aminothiazole KY-05009 with Potential to Inhibit Traf2- and Nck-Interacting Kinase (TNIK) Attenuates TGF-β1-Mediated Epithelial-to-Mesenchymal Transition in Human Lung Adenocarcinoma A549 Cells

• Jiyeon Kim ,

  * E-mail: yeon@eulji.ac.kr (JK); hwan@krict.re.kr (SHK)

  Affiliation Department of Biomedical Laboratory Science, School of Medicine, Eulji University, Jung-gu, Daejeon, Republic of Korea

  ⨯
• Seong-Hee Moon,

  Affiliation Laboratory of Translational Therapeutics, Korea Research Institute of Chemical Technology, Yuseong-gu, Daejeon, Republic of Korea

  ⨯
• Bum Tae Kim,

  Affiliation Division of Drug Discovery Research, Korea Research Institute of Chemical Technology, Yuseong-gu, Daejeon, Republic of Korea

  ⨯
• Chong Hak Chae,

  Affiliation Drug Discovery Platform Technology Team, Korea Research Institute of Chemical Technology, Yuseong-gu, Daejeon, Republic of Korea

  ⨯
• Joo Yun Lee,

  Affiliation Drug Discovery Platform Technology Team, Korea Research Institute of Chemical Technology, Yuseong-gu, Daejeon, Republic of Korea

  ⨯
• Seong Hwan Kim

  * E-mail: yeon@eulji.ac.kr (JK); hwan@krict.re.kr (SHK)

  Affiliation Laboratory of Translational Therapeutics, Korea Research Institute of Chemical Technology, Yuseong-gu, Daejeon, Republic of Korea

  ⨯